Patent details

EP3372239 Title: ENGINEERED BOTULINUM NEUROTOXIN

Basic Information

Publication number:
EP3372239
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP181514928
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENGINEERED BOTULINUM NEUROTOXIN
French Title of Invention:
NEUROTOXINE BOTULIQUE INGÉNIÉRISÉE
German Title of Invention:
MANIPULIERTES BOTULINUMNEUROTOXIN
SPC Number:

Dates

Filing date:
13/03/2013
Grant date:
11/11/2020
EP Publication Date:
12/09/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/11/2020
EP B1 Publication Date:
11/11/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/03/2021
Expiration date:
13/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/11/2020
 
 

Name:
President and Fellows of Harvard College
Address:
17 Quincy Street, Cambridge, MA 02138, United States (US)

Inventor

1

Name:
PENG, Lisheng
Address:
China (CN)

2

Name:
STENMARK, Pål Erik Gustav
Address:
Sweden (SE)

3

Name:
BERNTSSON, Ronnie Per-Arne
Address:
Sweden (SE)

4

Name:
DONG, Min
Address:
United States (US)

Priority

Priority Number:
201261653214 P
Priority Date:
30/05/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/00; A61K 38/48; C07K 14/33; C12N 9/52;

Publication

European Patent Bulletin

Issue number:
202046
Publication date:
11/11/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages